Atlas Trials

H. Lee Moffitt Cancer Center and Research Institute

539 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch H. Lee Moffitt Cancer Center and Research Institute

RecordFirmDate
Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer (NCT05751941)H. Lee Moffitt Cancer Center and Research Institute2023-02-14
Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer (NCT05528133)H. Lee Moffitt Cancer Center and Research Institute2023-01-25
Dose Escalation/Dose Expansion Study of PRGN-3007 UltraCAR-T Cells in Patients With Advanced Hematologic and Solid Tumor Malignancies (NCT05694364)H. Lee Moffitt Cancer Center and Research Institute2023-01-25
Ending Tobacco Use Through Interactive Tailored Messaging for Cambodian People Living With HIV/AIDS (NCT05746442)H. Lee Moffitt Cancer Center and Research Institute2023-01-11
Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance of Lung Cancer (NCT05665504)H. Lee Moffitt Cancer Center and Research Institute2023-01-11
HPV Multilevel Intervention Strategies Targeting Immunization in Community Settings (HPV MISTICS) (NCT05677360)H. Lee Moffitt Cancer Center and Research Institute2023-01-09
Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma (NCT05526989)H. Lee Moffitt Cancer Center and Research Institute2022-12-28
Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Pancreatic Cancer Patients (NCT05675059)H. Lee Moffitt Cancer Center and Research Institute2022-12-21
STRONG Program for Cancer Patients (NCT05649969)H. Lee Moffitt Cancer Center and Research Institute2022-12-01
Enhancing Long-Term Smoking Abstinence Among Cervical Cancer Survivors (Project ACCESS) (NCT05645146)H. Lee Moffitt Cancer Center and Research Institute2022-11-29
Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma (NCT05628883)H. Lee Moffitt Cancer Center and Research Institute2022-11-22
Feasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination Immunotherapy (NCT05579847)H. Lee Moffitt Cancer Center and Research Institute2022-10-19
Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma (NCT05524935)H. Lee Moffitt Cancer Center and Research Institute2022-10-11
The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics (NCT05692596)H. Lee Moffitt Cancer Center and Research Institute2022-10-06
DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer (NCT05504707)H. Lee Moffitt Cancer Center and Research Institute2022-08-26
Exploring Men s Prostate Cancer Genetic Risk Perceptions (NCT06764992)H. Lee Moffitt Cancer Center and Research Institute2022-08-25
Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Gastroesophageal Cancer (GEC) Patients (NCT05438940)H. Lee Moffitt Cancer Center and Research Institute2022-07-15
Early Supportive Care and Nutritional Support in Adults With Pancreatic Cancer (NCT05438927)H. Lee Moffitt Cancer Center and Research Institute2022-07-15
Exercise to Boost Response to Checkpoint Blockade Immunotherapy (NCT05358938)H. Lee Moffitt Cancer Center and Research Institute2022-06-21
"COACH" Study: Individualized COaching in Young Adult Cancer Survivors to Encourage Healthy Behaviors (NCT05434702)H. Lee Moffitt Cancer Center and Research Institute2022-06-20
Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine & Pepinemab /Trastuzumab in Patients w/ Metastatic HER2+ Breast Cancer (NCT05378464)H. Lee Moffitt Cancer Center and Research Institute2022-05-31
Habitat Escalated Adaptive Therapy (HEAT), With Neoadjuvant Radiation for Soft Tissue Sarcoma (NCT05301283)H. Lee Moffitt Cancer Center and Research Institute2022-05-18
Caregiver Protocol for Remotely Improving, Monitoring, and Extending Quality of Life (NCT05379933)H. Lee Moffitt Cancer Center and Research Institute2022-05-11
Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer (NCT05316129)H. Lee Moffitt Cancer Center and Research Institute2022-04-28
Multiple Myeloma Outcomes Based on Maintenance Therapy Post Autologous Stem Cell Transplant (NCT05271630)H. Lee Moffitt Cancer Center and Research Institute2022-04-20
Gamma Delta T-cell Infusion for AML at High Risk of Relapse After Allo HCT (NCT05015426)H. Lee Moffitt Cancer Center and Research Institute2022-03-21
Maintenance Fedratinib to Prevent Post-Transplant Relapse in Myeloproliferative Neoplasms (NCT05127174)H. Lee Moffitt Cancer Center and Research Institute2022-03-14
Preop fSRS for Resectable Brain Metastases (NCT05267587)H. Lee Moffitt Cancer Center and Research Institute2022-03-11
DASH INtervention to INvestigate the Gut (NCT04538482)H. Lee Moffitt Cancer Center and Research Institute2022-03-07
Fedratinib in Myelodysplastic /Myeloproliferative Neoplasms (MDS/MPNs) and Chronic Neutrophilic Leukemia (CNL) (NCT05177211)H. Lee Moffitt Cancer Center and Research Institute2022-03-01
Vyxeos Plus Gilteritinib in Relapsed or Refractory, FLT3-Mutated AML (NCT05024552)H. Lee Moffitt Cancer Center and Research Institute2022-02-25
Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization (NCT04879940)H. Lee Moffitt Cancer Center and Research Institute2022-02-23
First Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate Cancer (NCT05189457)H. Lee Moffitt Cancer Center and Research Institute2022-01-25
Adaptive Radiation for Locally Advanced Rectal Adenocarcinoma (NCT05108428)H. Lee Moffitt Cancer Center and Research Institute2021-12-23
Study of Screening Brain MRIs in Stage IV Breast Cancer (NCT05115474)H. Lee Moffitt Cancer Center and Research Institute2021-12-21
Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma (NCT05170334)H. Lee Moffitt Cancer Center and Research Institute2021-12-15
Automated Video-Assisted Smoking Treatment for People Living With HIV (NCT05014282)H. Lee Moffitt Cancer Center and Research Institute2021-12-15
Partnering With Food Bank to Provide Tobacco Treatment to Underserved Smokers (NCT05004662)H. Lee Moffitt Cancer Center and Research Institute2021-12-01
Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Cancer Brain Metastases (NCT04923542)H. Lee Moffitt Cancer Center and Research Institute2021-11-30
Duvelisib in Combination With BMS-986345 in Lymphoid Malignancy (NCT05065866)H. Lee Moffitt Cancer Center and Research Institute2021-11-18
Comparing Pre-Anesthesia Evaluation Via Telemedicine Versus in Person for Surgical Patients at Moffitt Cancer Center (NCT05065944)H. Lee Moffitt Cancer Center and Research Institute2021-11-16
SELINEXOR in Combination w/Bevacizumab and Atezolizumab in Newly Diagnosed Advanced Hepatocellular Carcinoma (NCT05093608)H. Lee Moffitt Cancer Center and Research Institute2021-11-03
Using Aspirin to Improve Immunological Features of Ovarian Tumors (NCT05080946)H. Lee Moffitt Cancer Center and Research Institute2021-11-02
CARES-HCV: Promoting Screening Uptake Among Diverse Baby Boomers (NCT04980157)H. Lee Moffitt Cancer Center and Research Institute2021-11-01
Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab (NCT05325632)H. Lee Moffitt Cancer Center and Research Institute2021-10-28
Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma (NCT04975152)H. Lee Moffitt Cancer Center and Research Institute2021-10-22
Effect of Prolonged Nightly Fasting on Immunotherapy Outcomes in HNSCC - Role of Gut Microbiome (NCT05083416)H. Lee Moffitt Cancer Center and Research Institute2021-10-20
Reducing Weight and Elevated Stress Levels Using Educational and Behavioral Tools (NCT04335799)H. Lee Moffitt Cancer Center and Research Institute2021-10-12
Capecitabine In Combination With Cemiplimab In Patient With Metastatic Breast Cancer (NCT05064085)H. Lee Moffitt Cancer Center and Research Institute2021-10-12
Study of Afatinib in Advanced Cutaneous Squamous Cell Carcinoma (NCT05070403)H. Lee Moffitt Cancer Center and Research Institute2021-10-01
Evaluating Stress Management Among Allogeneic HCT Caregivers (NCT05078229)H. Lee Moffitt Cancer Center and Research Institute2021-09-16
COVID-19 Immunogenicity of a Third Dose of mRNA-1273 Vaccine Among Cancer Patients (NCT05054218)H. Lee Moffitt Cancer Center and Research Institute2021-09-10
NPWT in Patients Undergoing Surgical Procedures for Management of GI Malignancies (NCT04955730)H. Lee Moffitt Cancer Center and Research Institute2021-08-05
Axitinib + Ipilimumab in Advanced Melanoma (NCT04996823)H. Lee Moffitt Cancer Center and Research Institute2021-08-04
Adaptation Of An HPV Education Resource To Promote HPV Vaccination (NCT04974619)H. Lee Moffitt Cancer Center and Research Institute2021-07-23
Clinical Trials Outreach & Education (NCT05064423)H. Lee Moffitt Cancer Center and Research Institute2021-06-15
Motivating a Spectrum of Cancer Patients to Quit Smoking (NCT04914000)H. Lee Moffitt Cancer Center and Research Institute2021-06-14
Project HEALS (Helping and Empowering pAtients for Living a Life Smoke-free (NCT05362318)H. Lee Moffitt Cancer Center and Research Institute2021-06-07
Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell Carcinoma (NCT04869137)H. Lee Moffitt Cancer Center and Research Institute2021-05-28
Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma (NCT04741997)H. Lee Moffitt Cancer Center and Research Institute2021-05-24
Study to Develop a Group-Based E-Health Intervention for YA Cancer Survivors (NCT05048316)H. Lee Moffitt Cancer Center and Research Institute2021-05-11
Combination of Ipi/Nivo Plus Sacituzumab Govitecan in Metastatic Cisplatin Ineligible Urothelial Carcinoma Patients (NCT04863885)H. Lee Moffitt Cancer Center and Research Institute2021-04-30
Total Tumor Mapping (TTM) for Resectable Pancreatic Cancer (NCT03718650)H. Lee Moffitt Cancer Center and Research Institute2021-04-01
Canakinumab With Darbepoetin Alfa in PTs With Lower-Risk MDS Who Have Failed ESA (NCT04798339)H. Lee Moffitt Cancer Center and Research Institute2021-03-30
Optimizing Cellular and Humoral Immunity by Vaccinating With PCV13 Before and After CAR-T Therapy (NCT04745559)H. Lee Moffitt Cancer Center and Research Institute2021-02-18
Health Beliefs, Behaviors, and Healthcare Experiences Among United States Young and Mid-Age Adults (NCT04766164)H. Lee Moffitt Cancer Center and Research Institute2021-02-17
CD8 Depleted, Non-engrafting, HLA Mismatched Unrelated Infusion With MDS and Secondary AML (NCT04620681)H. Lee Moffitt Cancer Center and Research Institute2021-01-14
Evolutionary Therapy for Rhabdomyosarcoma (NCT04388839)H. Lee Moffitt Cancer Center and Research Institute2020-12-29
Neoadjuvant Immunotherapy With Tavo + Electroporation in Combination With Nivo. in Melanoma Patients (NCT04526730)H. Lee Moffitt Cancer Center and Research Institute2020-12-22
Addressing Barriers to Palliative Care Use in Bladder Cancer (NCT04598724)H. Lee Moffitt Cancer Center and Research Institute2020-12-22
Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal Disease (NCT04588545)H. Lee Moffitt Cancer Center and Research Institute2020-12-10
PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer Patient (NCT03295695)H. Lee Moffitt Cancer Center and Research Institute2020-12-01
Immune Checkpoint Inhibition With Lurbinectedin Relapsed/Recurrent SCLC (NCT04610658)H. Lee Moffitt Cancer Center and Research Institute2020-11-23
Evaluation of EnVisio SmartClip for Intraoperative Localization of Breast Masses (NCT04604561)H. Lee Moffitt Cancer Center and Research Institute2020-10-27
Study of CG0070 Combined With Nivolumab in Cisplatin Ineligible Patients With MIBC (NCT04610671)H. Lee Moffitt Cancer Center and Research Institute2020-10-26
SARS-CoV-2 (COVID-19) Immune Surveillance Among a Population Based Sample of Adults in Florida (NCT04596579)H. Lee Moffitt Cancer Center and Research Institute2020-10-17
Cryotherapy for GAVE (NCT04760873)H. Lee Moffitt Cancer Center and Research Institute2020-10-14
IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients (NCT04562129)H. Lee Moffitt Cancer Center and Research Institute2020-09-24
Clinical Trial of Green Tea Catechins in Men on Active Surveillance (NCT04300855)H. Lee Moffitt Cancer Center and Research Institute2020-08-21
Quality of Life Model for Older Patients With AML (NCT04380441)H. Lee Moffitt Cancer Center and Research Institute2020-07-08
Immunonutrition to Reduce Toxicities in Non-Small Cell Lung Cancer (NCT03628144)H. Lee Moffitt Cancer Center and Research Institute2020-07-01
Colorectal Cancer Awareness, Research and Education and Screening - Rural Expansion, Access and Capacity for Health (NCT04464668)H. Lee Moffitt Cancer Center and Research Institute2020-06-25
Cemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCC (NCT04242173)H. Lee Moffitt Cancer Center and Research Institute2020-06-25
Generating Novel Therapeutic Strategies Based on Evolutionary Tumor Board (NCT04343365)H. Lee Moffitt Cancer Center and Research Institute2020-05-05
Randomized, Phase II Clinical Trial of Sulforaphane in Bladder Cancer Chemoprevention (NCT03517995)H. Lee Moffitt Cancer Center and Research Institute2020-04-01
Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported Outcomes (NCT04319237)H. Lee Moffitt Cancer Center and Research Institute2020-03-10
Contrast-Enhanced Ultrasound for the Evaluation of Changes in Tumor Blood Flow Surrounding HAE (NCT04150874)H. Lee Moffitt Cancer Center and Research Institute2020-02-19
Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas (NCT04275557)H. Lee Moffitt Cancer Center and Research Institute2020-02-18
Electronic Social Network Assessment Program (eSNAP) + Caregiver Navigator (NCT04268979)H. Lee Moffitt Cancer Center and Research Institute2020-02-13
Barriers to Screening Breast MRI Utilization Among Patients at Elevated Risk (NCT04257474)H. Lee Moffitt Cancer Center and Research Institute2020-01-30
Biological Outcomes of Pramlintide in Resectable Cutaneous Squamous Cell Carcinoma: A Pilot Study (NCT04252612)H. Lee Moffitt Cancer Center and Research Institute2020-01-30
Feasibility Study for Electroacupuncture for Chemotherapy- Induced Peripheral Neuropathy (CIPN) (NCT04092764)H. Lee Moffitt Cancer Center and Research Institute2020-01-23
PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores (NCT03495427)H. Lee Moffitt Cancer Center and Research Institute2019-12-18
Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies (NCT04191187)H. Lee Moffitt Cancer Center and Research Institute2019-12-06
Daratumumab Based Response Adapted Therapy for Older Adults With Newly Diagnosed Multiple Myeloma (NCT04151667)H. Lee Moffitt Cancer Center and Research Institute2019-11-22
Treatment Free Remission After Combination Therapy With Ruxolitinib Plus Tyrosine Kinase Inhibitors (NCT03610971)H. Lee Moffitt Cancer Center and Research Institute2019-11-19
TGR-1202 (Umbralisib) in Treatment Naïve Patients With Chronic Lymphocytic Leukemia (CLL) (NCT04163718)H. Lee Moffitt Cancer Center and Research Institute2019-11-12
Utilizing Augmented Reality as an Adjunct for Smoking Cessation (NCT04101422)H. Lee Moffitt Cancer Center and Research Institute2019-10-07
Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma (NCT03628209)H. Lee Moffitt Cancer Center and Research Institute2019-10-03
Lymphodepletion Plus Adoptive Cell Therapy With High Dose IL-2 in Adolescent and Young Adult Patients With Soft Tissue Sarcoma (NCT04052334)H. Lee Moffitt Cancer Center and Research Institute2019-09-27
← Previous Next →

Track H. Lee Moffitt Cancer Center and Research Institute automatically

Every clearance here is in the API, with alerts when new ones post.